Code | CSB-AP005421HU |
MSDS | |
Size | $116 |
Order now | |
Image | |
Have Questions? | Leave a Message or Start an on-line Chat |
Our Recombinant Human CA8 protein serves as a valuable research tool for scientists studying cancer biology. Carbonic anhydrase-related protein (CARP), also known as CA8, is expressed in E. coli and features a partial expression region from 2-290aa. The protein is fused with a C-terminal 6xHis-tag for easy purification and identification. The lyophilized powder format allows for simple reconstitution with sterile water or buffer, accommodating various experimental requirements.
The Recombinant Human CA8 protein demonstrates high quality and performance, with a purity greater than 95%, as determined by SDS-PAGE analysis. Furthermore, endotoxin levels are maintained below 1.0 EU/µg, as assessed by the LAL method. The protein exhibits esterase activity greater than 100 pmol/min/ug, highlighting its functionality for relevant applications.
Human CA8 has been the focus of numerous research studies due to its implications in cancer biology. For instance, Ghandour et al. (2007)[1] and Maresca et al. (2013)[2] contributed to a better understanding of the function and potential clinical applications of CA8. These studies emphasize the role of CA8 in cellular processes and its potential therapeutic value in cancer treatment.
References:
1. Ghandour H, et al. Carbonic anhydrase-related protein (CARP VIII) in cancer. Subcell Biochem. 2014;75:217-34.
2. Maresca A, et al. Potential therapeutic agents for the treatment of carbonic anhydrase-related diseases. Expert Opin Ther Pat. 2013;23(7):883-95.
There are currently no reviews for this product.